These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16912814)

  • 21. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Dechant KL; Clissold SP
    Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of antidepressants in depression: A systematic review and meta-analysis.
    Yuan Z; Chen Z; Xue M; Zhang J; Leng L
    J Clin Neurosci; 2020 Oct; 80():169-181. PubMed ID: 33099342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.
    Musselman DL; Somerset WI; Guo Y; Manatunga AK; Porter M; Penna S; Lewison B; Goodkin R; Lawson K; Lawson D; Evans DL; Nemeroff CB
    J Clin Psychiatry; 2006 Feb; 67(2):288-96. PubMed ID: 16566626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressants for insomnia in adults.
    Everitt H; Baldwin DS; Stuart B; Lipinska G; Mayers A; Malizia AL; Manson CC; Wilson S
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010753. PubMed ID: 29761479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites.
    Matsuzawa-Yanagida K; Narita M; Nakajima M; Kuzumaki N; Niikura K; Nozaki H; Takagi T; Tamai E; Hareyama N; Terada M; Yamazaki M; Suzuki T
    Neuropsychopharmacology; 2008 Jul; 33(8):1952-65. PubMed ID: 17957217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy.
    Holliday SM; Plosker GL
    Drugs Aging; 1993; 3(3):278-99. PubMed ID: 8324301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressants plus benzodiazepines for adults with major depression.
    Ogawa Y; Takeshima N; Hayasaka Y; Tajika A; Watanabe N; Streiner D; Furukawa TA
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD001026. PubMed ID: 31158298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depression comorbid with anxiety or medical illness: The role of paroxetine.
    Rouillon F
    Int J Psychiatry Clin Pract; 2001; 5(1):3-10. PubMed ID: 24936987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressants for the treatment of depression in people with cancer.
    Vita G; Compri B; Matcham F; Barbui C; Ostuzzi G
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD011006. PubMed ID: 36999619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.
    Ruhé HG; Huyser J; Swinkels JA; Schene AH
    J Clin Psychiatry; 2006 Dec; 67(12):1836-55. PubMed ID: 17194261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide.
    Pini S; Amador XF; Dell'Osso L; Baldini Rossi N; Cassano P; Savino M; Cassano GB
    Int Clin Psychopharmacol; 2003 Jan; 18(1):15-21. PubMed ID: 12490770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales.
    Sugarman MA; Loree AM; Baltes BB; Grekin ER; Kirsch I
    PLoS One; 2014; 9(8):e106337. PubMed ID: 25162656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paroxetine: a selective serotonin reuptake inhibiting antidepressant.
    Caley CF; Weber SS
    Ann Pharmacother; 1993 Oct; 27(10):1212-22. PubMed ID: 8251692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressants for patients with tinnitus.
    Baldo P; Doree C; Molin P; McFerran D; Cecco S
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD003853. PubMed ID: 22972065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Citalopram versus other anti-depressive agents for depression.
    Cipriani A; Purgato M; Furukawa TA; Trespidi C; Imperadore G; Signoretti A; Churchill R; Watanabe N; Barbui C
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD006534. PubMed ID: 22786497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
    Gunasekara NS; Noble S; Benfield P
    Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials.
    Maslej MM; Furukawa TA; Cipriani A; Andrews PW; Mulsant BH
    JAMA Psychiatry; 2020 Jun; 77(6):607-617. PubMed ID: 32074273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.